In the case of ovarian cancer, the analysis of a cohort of serous tumors has revealed that TENM2 expression is significantly lower in poorly differentiated (grade III) and undifferentiated tumors, compared to well differentiated (grade I and II) tumors. This evidence concerns the gene TENM2 and ovarian cancer.